Education

1985 Doctor of Medicine University of Colorado School of Medicine Denver, Colorado

1978 Bachelor of Science, Biology Hobart and William Smith Colleges Geneva, New York

Postdoctoral Training

1988-1991 Fellow, Hematology/Oncology, University of Colorado Health Sciences Center Denver, Colorado

1986-1988 Resident, Internal Medicine Residency Program, University of Utah Medical CenterSalt Lake City, Utah

1985-1986 Intern, Internal Medicine Residency Program, Hennepin County Medical Center Minneapolis, Minnesota

Certification/Board Eligibility

2001, 2011 Recertification - Medical Oncology

1991 Medical Oncology

1991 Hematology (eligible)

1988 Internal Medicine

Professional Societies

American College of Physicians (ACP) – Active Member
        A. Elected Fellow 2010

National Surgical Adjuvant Breast and Bowel Project (NSABP) - Active Member

American Society of Clinical Oncology (ASCO) - Active Member 
        A.  ASCO Publication Committee  
              Appointed Member 6/2004-6/2007
              Chair 6/2007-2008
        B.  ASCO Program Committee  
             Appointed Member 6/2008-6/2011
        C.  ASCO Prevention Committee  
              Appointed Member 6/2009-6/2012
        D.  ASCO IMT Committee  
             Appointed Member 6/2010-6/2013

Alliance for Clinical Trials in Oncology (Alliance) - Active Member
        A.  Prevention Subcommittee
             Appointed Member 2005- 2011
             Vice Chair 2006-2011
        B.  CCHO Committee
             Executive Committee 2005-present

Action Alliance Cooperative Committee - Active Member
              Prevention Committee
              Vice Chair 2011 – present

Publications

For a complete list of Marie Wood's publications, please visit PubMed.

George TJ, Manochakian R, Wood M, Polansky M, Baer A, Grupe A, Shyr Y, Wang C, Williams J, Horn L. Quantitative Analysis of Oncology Professional Learning Preferences. JCO Oncol Pract. 2020 Feb;16(2):e155-e165. doi: 10.1200/JOP.18.00731. PMID: 32045553

Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, Adank MA, Adlard J, Aittomaki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg a, Blomqvist C, Claes KBM, Concannon P, Cuggia A, Culver JO, Damiola F, de Pauw A, Diez O, Dolinsky JS, Domchek SM, Engel C, Evans DG, Fostira F, Garber J, Goode EL,Gruber SB, Hahnen E, Hake C, Heikkinen T, Hurley JE, Janavicius R, Kleibl Z, Kleiblova P, Konstantopoulou I, Kvist A, Laduca H, Lee ASG, Lesueur F, Maher ER, Mannermaa A, Manoukian S, McFarlandd R, McKinnon W, Meindl A, Metcalfe K, Mohd Taib NA, Moilanen J, Nathanson KL, Nehausen S, Nq PS, Nguyen-Dumont T, Nielsen SM, Obrmair F, Offit K, Olopade OI, Ottini L, Penkert J, Pylkas K, Radice P, Ramus SJ, Rudaitis V, Side L, Silva-Smith R, Silvestri V, Skytte AB, Slavin T, Soukupova J, Tondini C, Trainer AH, Unzeitig G, Usha L, van Overeem Hansen T, Whitmore J, Wood M, Yip CH, Yoon SY, Yussuf A, Zoqopoulos G, Goldgar D, Hopper JL, Chenevix-Trench G, Pharoah P, George SHL, Balmana J, Houdayer C, James P, El-Haffaf Z, Ehrencrona H, Janatova M, Peterlongo P, Nevanlinna H, Schmutzler R, Teo SH Robson M, Pal T, Couch F, Weitzel JN, Elliott A, Southey M, Wingvist R, Easton DF, Foulkes WD, Antoniou AC, Tischkowitz M. Cancer Risks Associated with Germline PALB2 Pathogenic Variants: An International Study of 524 Families. J Clin Oncol. 2019 Dec 16: JCO1901907. doi: 10.1200/JCO.19.01907. PMID: 31841383

Krok-Schoen JL, Naughton MJ, Young GS, Moon J, Poi M, Melin SA, Wood ME, Hopkins JO, Paskett ED, Post DM. Increasing Adherence to Adjuvant Hormone Therapy Among Patients with Breast Cancer: A Smart Phone App-Based Pilot Study. Cancer Control. 2019 Jan-Dec;26(1): 1073274819883287. doi: 10.1177/1073274819883287. PMID: 31736324

Manochakian R, George TJ, Wood M, Polansky M, Baer A, Grupe A, Shyr Y, Wang C, Horn L. Establishing and Evaluating an ASCO Learning Cohort: a Longitudinal Project Assessing the Learning Needs and Behaviors of Oncology Professionals. J Cancer Educ. 2019 Nov 18. doi: 10.1007/s13187-019-01649-5. PMID: 31741200

Wood ME, Garber JE, Isaacs C, Masood S, Bedrosian I, Tung N, Chun J, Schnabel FR, Arun BK; International Society of Cancer Risk Assessment and Management. Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations. Breast J. 2019 Jul;25(4):575-577. doi: 10.1111/tbj.13292. PMID: 31280501

Wood M, George TJ, Manochakian R, Polansky M, Baer A, Grupe A, Shyr Y, Wang C, Horn L. Quantitative Assessment of Learning Behaviors for Oncology Providers. J Cancer Educ. 2019 Aug 3. doi: 10.1007/s13187-019-01593-4. PMID: 31377987

Wood ME, Cuke M, Bedrosian I. Prevention Therapy for Breast Cancer. How Can We      Do Better? Ann Surg Oncol. 2019 Feb 23. doi: 10.1245/s10434-019-07243-9. [Epub ahead of print] No abstract available. PMID: 30798445

Wood ME, Farina NH, Ahern TP, Cuke ME, Stein JL, Stein GS, Lian JB. Towards a more precise and individualized assessment of breast cancer risk. Aging (Albany NY). 2019 Feb 20;11(4):1305-1316. doi: 10.18632/aging.101803. PMID: 30787204

Selected publications:

Witherby S, Johnson J, Demers L, Mount S, Littenberg B, Maclean CD, Wood M, Muss H:  Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to Aromatase Inhibitors:  A Phase I/II Study.  The Oncologist.  16(4):424-431, 2011.

Cigler T, Richardson H, Yaffe MJ, Fabian CJ, Johnston D, Ingle JN, Nassif E, Brunner RL, Wood ME, Pater JL, Hu H, Qi S, Tu D, Goss PE:  A randomized, placebo-controlled trial (NCIC CTG MAP .2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lip levels in postmenopausal women.  Breast Cancer Res Treat 126(2):453-461, 2011.  (Epub ahead of print Jan 9 2010).

Lubinski J, Murphy J, Shaw P, Domchek S, Kauff N, Offit K, Isaacs C, Tung N,  Olopade O, Foulkes W, Gilchrist D, Manoukian S, McLennan J, Friedman E,  Eisen A, Rennert G, Saal H, Weitzel J, Klijn JG, Fallen T, McKinnon W, Wood  M, Donenberg T, Gronwald J, Huzarski T:  Risk factors for carcinoma of the  fallopian tube in women with and without a germline BRCA mutation.  Gynecol  Oncol 2010 Aug 118(2):155-9 2010.

Ginsburg O, Ghadirian P, Lynch H. Neuhausen S, Kim-Sing C, Robson, M.  Domchek S, Isaacs C, Armel S, Foulkes W, Tung N, Olopade O, Cummings S,  Couch F, Rosen B, Horsman D, Saal H, Warner E, Meschino W, Offit K, Trivedi  A, Osburne M, Gilchrist D, Eng C, Weitzel J, McKinnon W, Wood M, Maugard  C, Ainsworth P, Sweet K, Pasche B, Karlan B, Kurz R, Tulman A, Lemire E,  Mclennan J, Evans G, Elsen A, Daly M, Garber J, Merajver S:  Fertility in women  with BRCA mutations: A case-control study.  Fertil Steril, 2010 Apr 93(6):1805-8.

Wood ME, Fama TA, Ashikaga T, Muss HB: Discrepancy Between Preference  and Actual Adjuvant Therapy for Breast Cancer. Clin Breast Cancer  Oct 1;10(5):398-403, 2010.